Back to Newsroom

International Stem Cell Corporation Presents Comprehensive Findings for Parkinson’s Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015

CARLSBAD, CA–(Marketwired – October 14, 2015) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company will make an oral presentation on the comprehensive results of its preclinical development of human parthenogenetic neural stem cells (hPNSCs) for the treatment of Parkinson’s Disease at Neuroscience 2015 in Chicago.

Click here to read more